• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS CA 15-3 II ASSAY; TUMOR-ASSOCIATED ANTIGEN IMMUNOLOGICAL TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS CA 15-3 II ASSAY; TUMOR-ASSOCIATED ANTIGEN IMMUNOLOGICAL TEST SYSTEM Back to Search Results
Catalog Number 03045838122
Device Problem Low Test Results (2458)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/23/2016
Event Type  malfunction  
Manufacturer Narrative
(b)(4).This event occurred in (b)(6).
 
Event Description
The customer received questionable elecsys ca 15-3 ii assay results for several samples for one patient when compared to the results from an architect analyzer.Information about the analyzer used was requested but was not provided.The result of 25.0 from (b)(6) 2017 was reported to the physician.It was unknown which results were correct for the patient.The patient was not adversely affected.The customer performed dilutions to rule out a hook effect: initial result: 30.37 ui/ml.Diluted at 5:15 (manual): 82.65 ui/ml.Diluted at 1:10 (instrument): 106.4 ui/ml.Possible reasons for difference in the results include the use of different ca15-3 antibodies in the different assays, the different antibodies could recognize different parts of the molecule, antigen heterogeneity, the lack of an international standard for ca15-3, and the different assay formats.
 
Manufacturer Narrative
Samples from the patient were submitted for investigation and were tested by a third party method.The results from the abbott ca 15-3 assay were confirmed.
 
Manufacturer Narrative
As part of the investigation, the samples were tested on a cobas 6000 e 601 module and the results were verified.A specific root cause could not be identified.There was no evidence of an interfering substance or hama interference.Product labeling for the assay documents different results can be found for ca 15-3 when using different methods.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS CA 15-3 II ASSAY
Type of Device
TUMOR-ASSOCIATED ANTIGEN IMMUNOLOGICAL TEST SYSTEM
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key6403544
MDR Text Key69954031
Report Number1823260-2017-00555
Device Sequence Number1
Product Code MOI
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K010588
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 05/22/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/14/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number03045838122
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Date Manufacturer Received02/27/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Treatment
MORPHINE; MOUTHWASH WITH BICARBONATE
-
-